Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

+4.1%avg per buy, ~6 months on+7.1%S&P 500 avg, same spans
MAIA · 2022-09-19 · +6.5%MAIA · 2025-06-03 · -47.9% (S&P +10.6%)MAIA · 2025-10-01 · -11.4% (S&P -1.7%)MAIA · 2025-11-24 · +24.4% (S&P +9.7%)MAIA · 2025-11-25 · +33.0% (S&P +9.8%)MAIA · 2025-11-26 · +20.8% (S&P +9.3%)MAIA · 2025-12-05 · +8.3% (S&P +9.5%)MAIA · 2025-12-22 · -0.8% (S&P +9.6%)
2022-09-192025-12-22
Each dot: one completed buy’s ~6-month outcome, equal weight per buy · dashed: S&P 500 over the same spans · hover a dot for detail
5 of 8
buys higher ~6mo later
+8.3%
median outcome
+9.6%
S&P 500 median, same spans

1 buy still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.20M
combined est. value
MAIA
MAIA Biotechnology, Inc.
$2.20M
1,519,178 sh

Activity

Open-market buy & sell volume

BuySell
0$101K$202K2022 · bought $10K · sold $020222025 · bought $202K · sold $020252026 · bought $100K · sold $02026
Total +$311.8K bought
Most bought
MAIA
$311.8K

All filings on record

Every Form 4 transaction we track for this filer

MAIABuy
2026-06-01 · MAIA Biotechnology, Inc.
$100.2K
in progress
MAIABuy
2025-12-22 · MAIA Biotechnology, Inc.
$70.0K
-0.8%
MAIABuy
2025-12-05 · MAIA Biotechnology, Inc.
$5.5K
+8.3%
MAIABuy
2025-12-05 · MAIA Biotechnology, Inc.
$5.5K
+8.3%
MAIABuy
2025-12-05 · MAIA Biotechnology, Inc.
$5.5K
+8.3%
MAIABuy
2025-11-26 · MAIA Biotechnology, Inc.
$15.6K
+20.8%
MAIABuy
2025-11-25 · MAIA Biotechnology, Inc.
$14.7K
+33.0%
MAIABuy
2025-11-24 · MAIA Biotechnology, Inc.
$9.9K
+24.4%
MAIABuy
2025-10-01 · MAIA Biotechnology, Inc.
$25.0K
-11.4%
MAIABuy
2025-06-03 · MAIA Biotechnology, Inc.
$50.0K
-47.9%
MAIAGift
2024-05-01 · MAIA Biotechnology, Inc.
20,000
—
MAIABuy
2022-09-19 · MAIA Biotechnology, Inc.
$10.0K
+6.5%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.